Login to Your Account



'Deep-Priming' technology adds new 'Torque' to cancer immunotherapy

By Marie Powers
News Editor

Tuesday, November 14, 2017

Torque Therapeutics Inc. emerged from the deep, disclosing a series A by Flagship Pioneering that was opened in conjunction with its founding in 2015 and, with a second tranche pulled down in August, amounts to $25 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription